Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00360269 · ClinicalTrials.gov registry record · Phase 2
Atomoxetine Treatment for ADHD and Marijuana Dependence
A Phase 2 study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 2
- Development phase
- 38
- Enrollment target
NCT00360269 is a Phase 2 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 38 participants.
The verdict
NCT00360269, a Phase 2 study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 38 participants
- Enrollment target
Study Summary
The aim of the study is to determine if atomoxetine treatment combined with motivational enhancement therapy is effective in reducing marijuana use in adult individuals with attention-deficit hyperactivity disorder and marijuana dependence.
Interventions
- DRUG Placebo
- DRUG Atomoxetine
- PROCEDURE Motivational enhancement therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2005-11 |
| Est. Completion | 2008-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00360269
The ClinicalTrials.gov registry entry for NCT00360269 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00360269 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00360269 about?
NCT00360269 is a clinical study titled "Atomoxetine Treatment for ADHD and Marijuana Dependence". The aim of the study is to determine if atomoxetine treatment combined with motivational enhancement therapy is effective in reducing marijuana use in adult individuals with attention-deficit hyperactivity disorder and marijuana dependence.
What is the current status of trial NCT00360269?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 38 participants. The study started on 2005-11. Estimated completion is 2008-06.
What interventions are being tested in trial NCT00360269?
The interventions under investigation include: Placebo (DRUG), Atomoxetine (DRUG), Motivational enhancement therapy (PROCEDURE).
Who is sponsoring clinical trial NCT00360269?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.